311 related articles for article (PubMed ID: 33144118)
41. Histone-mutant glioma presenting as diffuse leptomeningeal disease.
Nadkarni T; Hamilton K; Niazi F; Ward M; Okakpu U; Castellani RJ; Prisneac I; Sener U
CNS Oncol; 2021 Sep; 10(3):CNS75. PubMed ID: 34469205
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy.
Lee P; Murphy B; Miller R; Menon V; Banik NL; Giglio P; Lindhorst SM; Varma AK; Vandergrift WA; Patel SJ; Das A
Anticancer Res; 2015 Feb; 35(2):615-25. PubMed ID: 25667438
[TBL] [Abstract][Full Text] [Related]
43. The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.
Cecener G; Tunca B; Egeli U; Bekar A; Tezcan G; Erturk E; Bayram N; Tolunay S
Cell Mol Neurobiol; 2012 Mar; 32(2):237-44. PubMed ID: 21928112
[TBL] [Abstract][Full Text] [Related]
44. PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.
Dong F; Li Q; Yang C; Huo D; Wang X; Ai C; Kong Y; Sun X; Wang W; Zhou Y; Liu X; Li W; Gao W; Liu W; Kang C; Wu X
Nat Commun; 2018 Oct; 9(1):4552. PubMed ID: 30382083
[TBL] [Abstract][Full Text] [Related]
45. Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience.
Bezecny P
Med Oncol; 2014 Jun; 31(6):985. PubMed ID: 24838514
[TBL] [Abstract][Full Text] [Related]
46. Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis.
Markouli M; Strepkos D; Basdra EK; Papavassiliou AG; Piperi C
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803458
[TBL] [Abstract][Full Text] [Related]
47. The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer.
Yerlikaya A; Kanbur E; Stanley BA; Tümer E
Anticancer Agents Med Chem; 2021; 21(1):20-32. PubMed ID: 32781973
[TBL] [Abstract][Full Text] [Related]
48. Regulation of histone methylation by noncoding RNAs.
Joh RI; Palmieri CM; Hill IT; Motamedi M
Biochim Biophys Acta; 2014 Dec; 1839(12):1385-94. PubMed ID: 24954181
[TBL] [Abstract][Full Text] [Related]
49. Histone modification enzymes: novel targets for cancer drugs.
Kristeleit R; Stimson L; Workman P; Aherne W
Expert Opin Emerg Drugs; 2004 May; 9(1):135-54. PubMed ID: 15155140
[TBL] [Abstract][Full Text] [Related]
50. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells.
Kondo Y; Shen L; Ahmed S; Boumber Y; Sekido Y; Haddad BR; Issa JP
PLoS One; 2008 Apr; 3(4):e2037. PubMed ID: 18446223
[TBL] [Abstract][Full Text] [Related]
51. Post-translational modifications of histones H3 and H4 associated with the histone methyltransferases Suv39h1 and G9a.
Robin P; Fritsch L; Philipot O; Svinarchuk F; Ait-Si-Ali S
Genome Biol; 2007; 8(12):R270. PubMed ID: 18096052
[TBL] [Abstract][Full Text] [Related]
52. Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology.
Sesé B; Ensenyat-Mendez M; Iñiguez S; Llinàs-Arias P; Marzese DM
Clin Epigenetics; 2021 Jul; 13(1):150. PubMed ID: 34332627
[TBL] [Abstract][Full Text] [Related]
53. Altered histone modifications in gliomas.
Kim YZ
Brain Tumor Res Treat; 2014 Apr; 2(1):7-21. PubMed ID: 24926467
[TBL] [Abstract][Full Text] [Related]
54. Glioma epigenetics: From subclassification to novel treatment options.
Gusyatiner O; Hegi ME
Semin Cancer Biol; 2018 Aug; 51():50-58. PubMed ID: 29170066
[TBL] [Abstract][Full Text] [Related]
55. Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion.
Appikonda S; Thakkar KN; Shah PK; Dent SYR; Andersen JN; Barton MC
J Biol Chem; 2018 May; 293(19):7476-7485. PubMed ID: 29523690
[TBL] [Abstract][Full Text] [Related]
56. Heparanase expression is associated with histone modifications in glioblastoma.
Hong X; Nelson K; Lemke N; Kalkanis SN
Int J Oncol; 2012 Feb; 40(2):494-500. PubMed ID: 22001963
[TBL] [Abstract][Full Text] [Related]
57. Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma.
Pratap UP; Sareddy GR; Liu Z; Venkata PP; Liu J; Tang W; Altwegg KA; Ebrahimi B; Li X; Tekmal RR; Viswanadhapalli S; McHardy S; Brenner AJ; Vadlamudi RK
Neurooncol Adv; 2021; 3(1):vdab099. PubMed ID: 34485908
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.
Williams MJ; Singleton WG; Lowis SP; Malik K; Kurian KM
Front Oncol; 2017; 7():45. PubMed ID: 28401060
[TBL] [Abstract][Full Text] [Related]
59. Enhancer II-targeted dsRNA decreases GDNF expression via histone H3K9 trimethylation to inhibit glioblastoma progression.
Zhang B; Han X; Gao Q; Liu J; Li S; Zha W; Wang X; Guo X; Gao D
Brain Res Bull; 2021 Feb; 167():22-32. PubMed ID: 33278485
[TBL] [Abstract][Full Text] [Related]
60. Homeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissue.
Luo K; Luo D; Wen H
Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27160082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
